AlisonJillMoskowitzMD

PubMed

• Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
  Pier Luigi Zinzani, Gilles A Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D B...> ;Blood Advances. 2024 Mar 26
• BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cel...
  Robert Stuver, Agrima Mian, Samantha Brown, Sean Devlin, Paolo F Caimi, Stephanie Chinapen, Parastoo Dahi, Robert Dean, Zachary D Epstein-Peterson, Brian Hill, Steven ...> ;American Journal of Hematology. 2024 Mar 25
• Brentuximab Vedotin and Chemotherapy in Relapsed/Refractory Hodgkin Lymphoma: a Propensity Score Matched Analysis.
  Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Zinzani, Ann S LaCasce, Peter D Cole, Craig H Moskowitz, Ramón García-Sanz, Michael Fuchs, Horst Mueller, Peter ...> ;Blood Advances. 2024 Mar 19
• Current and upcoming treatment approaches to common subtypes of PTCL (PTCL NOS, ALCL, TFHs).
  Alison J Moskowitz, Robert N Stuver, Steven M Horwitz> ;Blood. 2024 Feb 2
• Matched control analysis suggests R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared to R-CHOP.
  Bantilan, K., Smith, A., Maurer, M., Teruya-Feldstein, J., Matasar, M., Moskowitz, A., Straus, D., Noy, A., Palomba, M., Horwitz, S., Hamlin, P., Portlock, C., Cerhan,...> ;Blood Advances. 2024 Jan 25
• Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes.
  Paola Ghione, Salma Ahsanuddin, Efrat Luttwak, Sabela Bobillo Varela, Reiko Nakajima, Laure Michaud, Kanika Gupta, Anastasia Navitski, David Straus, M Lia Palomba, Ali...> ;Haematologica. 2024 Jan 1
• Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma.
  Robert Stuver, Ariela Noy, Santosha A Vardhana, Andrew D Zelenetz, Alison J Moskowitz> ;British Journal of Haematology. 2024 Feb 1
• Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab.
  Robert Stuver, Santosha A Vardhana, Akshay Bedmutha, Karmela Kim Chan, Rosna Mirtcheva-Trocheva, Anton Nosov, Heiko Schöder, Alison Moskowitz> ;Leukemia & Lymphoma. 2023 Dec 1
• 1 citations
  Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma.
  Julia Driessen, Gerben J C Zwezerijnen, Heiko Schöder, Marie José Kersten, Alison J Moskowitz, Craig H Moskowitz, Jakoba J Eertink, Martijn W Heymans, Ronald Boellaard...> ;Blood Advances. 2023 Nov 14
• 1 citations
  Retrospective characterization of nodal marginal zone lymphoma.
  Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C Caron, Ahmet Dogan, Zachary D Epstein-Peterson, Lorenzo Falchi, Paul A Hamlin,...> ;Blood Advances. 2023 Sep 12
• 3 citations
  TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.
  William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver, Catherine R Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan...> ;Blood Advances. 2023 Sep 12
• 1 citations
  Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up.
  Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A Johnson, Neha Mehta-Shah, ...> ;Blood Advances. 2023 Sep 26
• 3 citations
  Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
  Robert Stuver, Steven M Horwitz, Ranjana H Advani, Julie M Vose, Hun Ju Lee, Neha Mehta-Shah, Jasmine M Zain, Bradley Haverkos, Mary Jo Lechowicz, Alison J Moskowitz, ...> ;British Journal of Haematology. 2023 Aug 1
• 2 citations
  Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting.
  Serena Zheng, Kanika Gupta, Piyush Goyal, Reiko Nakajima, Laure Michaud, Connie Lee Batlevi, Paul A Hamlin, Steven Horwitz, Anita Kumar, Matthew J Matasar, Alison J Mo...> ;Cancers. 2023 Mar 14
• 4 citations
  Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma.
  Armando Santoro, Alison J Moskowitz, Silvia Ferrari, Carmelo Carlo-Stella, Julie Lisano, Stephen Francis, Rachael Wen, Alev Akyol, Kerry J Savage> ;Blood. 2023 Jun 1
• 12 citations
  Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
  Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen, Nikita Kotlov, Grigorii Nos, Maria Sorokina, Vladislav Maksimov, Andrea Sboner, Michael Sig...> ;Blood. 2023 May 4
• 3 citations
  Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma.
  Robert Stuver, Alison J Moskowitz> ;Cancers. 2023 Jan 18
• 1 citations
  Osteonecrosis of the jaw associated with pembrolizumab.
  Isabel Pennings, Alison Moskowitz, Gunjan Shah, Cherry Estilo, Joseph M Huryn, SaeHee K Yom> ;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2023 Jul 1
• 1 citations
  Do all patients with primary refractory/first relapse of HL need autologous stem cell transplant?
  Alison J Moskowitz> ;Hematology. American Society of Hematology. Education Program. 2022 Dec 9
• The potential for technology to aid quantitative assessment in cutaneous T cell lymphoma.
  Lilly Gu, Yuna Oh, Mary P Smith, Nicholas R Kurtansky, Steven Horwitz, Niloufer Kahn, Alison Moskowitz, Sarah J Noor, Patricia Myskowski, Veronica Rotemberg> ;Leukemia & Lymphoma. 2022 Dec 1
• EXABS-208-HL Sequencing Novel Agents in Frontline and Second-Line Treatment of Hodgkin Lymphoma.
  Alison J Moskowitz> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• 16 citations
  The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics inF-FDG PET Scans of Patients with Classical Hodgkin...
  Julia Driessen, Gerben J C Zwezerijnen, Heiko Schöder, Esther E E Drees, Marie José Kersten, Alison J Moskowitz, Craig H Moskowitz, Jakoba J Eertink, Henrica C W de Ve...> ;Journal of Nuclear Medicine. 2022 Sep 1
• Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design.
  Anita Kumar, Carla Casulo, Erel Joffe, Craig Moskowitz, John Gerecitano, Alison Moskowitz, Anas Younes, Pamela Drullinsky, Esther Drill, Morgan Choma, Clare Grieve, As...> ;Leukemia & Lymphoma. 2022 Dec 1
• 1 citations
  Current Treatment of Peripheral T-cell Lymphoma.
  Robert Stuver, Zachary D Epstein-Peterson, William T Johnson, Niloufer Khan, Natasha Lewis, Alison J Moskowitz, Craig S Sauter, Steven Horwitz> ;Oncology. 2022 May 9
• 5 citations
  PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome.
  Natasha E Lewis, Qi Gao, Kseniya Petrova-Drus, Melissa Pulitzer, Allison Sigler, Jeeyeon Baik, Alison J Moskowitz, Steven M Horwitz, Ahmet Dogan, Mikhail Roshal> ;Cytometry. Part B, Clinical Cytometry. 2022 May 1
• Join now to see all

Abstracts/Posters

• Genomic Profiling of Mantle Cell Lymphoma Suggests Poor-Risk Profile Is Present at Diagnosis and Does Not Arise By Tumor Evolution
  Alison J. Moskowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Single-Institution Experience
  Alison J. Moskowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
  Alison J. Moskowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...
  Alison J. Moskowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)
  Alison J. Moskowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
  Alison J. Moskowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
  Alison J. Moskowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Pre-Transplant Salvage Options: Bringing Conventional Versus Novel Combinations to Practice 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
• High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell Lymphoma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Circulating Lymphoma Cells in Mycosis Fungoides/Sezary Syndrome Show Heterogeneity of the Cell-of-Origin and Variable PD-1 Expression By Flow Cytometric Analysis 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all